Mediterranean vs ketogenic diet: which has the evidence?
The Mediterranean diet is better supported, with randomized human outcome data on heart disease, while keto's proven wins are narrower (epilepsy, short-term metabolic markers) and its longevity claim, like the Mediterranean lifespan claim, remains untested in humans.
How they compare
Both the Mediterranean diet and the ketogenic diet get pitched as the eating pattern that will keep you healthier for longer, and both lean on a shared idea: that the right way to eat can slow age-related disease. Each also has a genuine, well-described mechanism behind part of its reputation, the Mediterranean diet through anti-inflammatory fats and polyphenols that improve blood-vessel function and lipids, keto through ketone signaling that dials down mTOR and switches on autophagy. People compare them because both promise more than weight loss: they promise added years.
The key difference the evidence reveals is how far each claim has actually been tested in humans. The Mediterranean diet has a randomized trial, PREDIMED, showing roughly a 30 percent drop in major cardiovascular events, a hard clinical outcome. Keto's strongest human proof is for drug-resistant epilepsy and short-to-medium-term weight and blood-sugar control; its longevity case rests on mouse studies, with no human trial showing it extends life.
The table
| Dimension | Mediterranean diet | Ketogenic diet |
|---|---|---|
| What it targets | Cardiovascular disease via olive oil, vegetables, legumes, nuts and oily fish that lower inflammation and improve lipids. | Metabolic state via very low carbohydrate, forcing ketosis and ketone signaling that lowers mTOR and raises autophagy. |
| Human evidence | PREDIMED RCT shows roughly 30 percent fewer major cardiovascular events; mortality benefit is observational only. | Proven for drug-resistant epilepsy and short-term weight and glucose control; no human lifespan or healthspan trial. |
| Size of the effect | About 30 percent fewer cardiovascular events in the trial; cohorts show roughly 9 percent lower all-cause mortality. | Roughly 12 percent weight loss and about 1.3 percent HbA1c drop at one year in a sponsor-funded, non-randomized study. |
| Funding and conflicts | PREDIMED mainly Spanish public funding, with olive oil and nuts donated by industry; mortality signal corroborated by an unfunded meta-analysis. | Independent NIH and academic money backs epilepsy and mouse data; industry and advocacy money (Virta, Citizen Science Foundation) backs the optimistic human messaging. |
| Best understood as | A heart-protective pattern that is a sound bet, with the lifespan promise likely but resting on observational data. | A powerful metabolic tool with specific proven uses, not a demonstrated longevity diet, with an open LDL safety question in some people. |
People also ask
- Is the Mediterranean diet or keto better for living longer?
- Neither has a human trial proving it extends lifespan. The Mediterranean diet has the stronger overall case because a randomized trial shows it cuts heart attacks and strokes by about 30 percent. Keto's proven benefits are narrower: epilepsy and short-to-medium-term metabolic markers.
- Which diet is safer long term?
- The Mediterranean diet carries fewer flagged safety concerns in these checks. Keto can drive LDL and ApoB very high in lean hyper-responders, a real open cardiovascular safety question, and long-term hard-endpoint data are absent. Both lack a trial measuring lifespan directly.
- Does either diet have randomized human evidence?
- Yes, but for different things. The Mediterranean diet's PREDIMED trial randomized people and measured cardiovascular events. Keto's randomized and controlled support centers on seizure reduction in epilepsy; its metabolic weight-loss data come largely from a sponsor-funded, non-randomized study, and its longevity signal is mouse-only.
The honest read
If the goal is heart health, the Mediterranean diet is the better-evidenced choice and a sound bet either way. Keto earns its place for epilepsy and short-to-medium-term metabolic control, but the sweeping longevity claim is unproven and, in some people, the LDL response is a genuine open safety question.
Caveat is journalism, not medical advice. We check public claims against published evidence; we don’t diagnose, treat, or tell you what to take.